NCT07040397

Brief Summary

The purpose of this study is to gather information about patient experience receiving a massage through a robotic EMMA (Expert Manipulative Massage Automation) compared to receiving a massage from a massage therapist.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Jan 2026Oct 2026

First Submitted

Initial submission to the registry

June 5, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 27, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

January 30, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

June 5, 2025

Last Update Submit

May 1, 2026

Conditions

Keywords

massageLow Back Painautomated massageEMMA (expert manipulative massage automation)electric massager

Outcome Measures

Primary Outcomes (1)

  • Number of patients enrolled

    Feasibility will be determined by the total number of patients screened in order to accrue the 40 needed to complete the study.

    baseline to end of study (year 2)

Study Arms (2)

Indirect person massage therapy

EXPERIMENTAL

A massage therapist will program and direct an Artificial Intelligence Robotic Arm (EMMA) to deliver massage therapy. EMMA executes massages through soft treatment modules that are warmed to a temperature of between 38℃ and 40℃ to mimic human touch. This treatment will last approximately 20 minutes.

Device: EMMA massage therapy

Direct person massage therapy

ACTIVE COMPARATOR

Clinical massage treatment procedures are delivered by a clinically licensed massage therapist. This treatment will last approximately 20 minutes.

Other: Clinical massage treatment

Interventions

Expert Manipulative Massage Automation (EMMA) is equipped with sensors to measure muscle stiffness and uses 3D vision technology to measure muscle stiffness and identify pressure points while delivering a massage to patients. Following that, the electronic massager will determine the best course of action for our patients based on the information stored by our Artificial Intelligence and EMMA's robotic arm will perform the massage. EMMA executes massages through soft treatment modules that are warmed to a temperature of between 38℃ and 40℃ to mimic human touch.

Indirect person massage therapy

The direct person clinical massage treatment will be delivered by a clinical licensed massage therapist. The type of massage will follow the EMMA massage in that it will be a deep tissue massage (to mimic the Tuina massage) and generally will be for about 30 minutes to once again mimic the duration of massage therapy of the EMMA.

Direct person massage therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be 18 years of age or older.
  • report a primary pain point in the lower back.
  • Pain intensity reported at baseline
  • Women of childbearing potential who self-report not being pregnant and agree to employ an effective method of birth control (surgical sterilization or oral contraceptives, barrier method with spermicides, intrauterine device, etc.) during the study period
  • be able to participate fully in all aspects of the study.
  • have understood and signed study informed consent.

You may not qualify if:

  • Pregnancy or breastfeeding
  • Patients with the inability to stay in a prone position
  • Patients with bleeding disorders
  • Patients with allergies and/or local skin affectations
  • have used pain medications or participated in a pain treatment within three days of study enrollment.
  • have an implanted device (including a lap band) in the targeted area of massage therapy.
  • have used an investigational drug within 30 days of study enrollment.
  • have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease.
  • have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, metabolic disease (such as uncontrolled diabetes type 2) active cancer, actively receiving treatment for cancer or within 1 year of cancer remission.
  • surgical intervention for pain within 1 month prior to enrollment.
  • active infection, wound or other external trauma to the areas to be treated with massage therapy.
  • have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Mueller

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: 20 will be randomized to EMMA and 20 to a certified massage therapist. Everyone will receive a massage treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 27, 2025

Study Start

January 30, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations